Prof. Dr. Turgay Çelikel
OncologyVerified
- 47+years exp.
English · Turkish
FromPrice on request
Free quote
60 seconds · no obligationView Profile
Cancer Surgery
Ocular oncology surgery
An overview of ocular oncology surgery for eye and orbital tumours, including plaque brachytherapy, local resection and enucleation. Learn what clinical evidence says about tumour control and vision preservation, compare approximate costs in Turkey with the UK, US and Germany, and understand surgical steps, recovery milestones, prosthetic eye fitting, potential risks and how to evaluate specialised surgical teams.
A written plan with the surgeon's name and the full price — usually within 24 hours.
- Category
- Cancer Surgery
- Hospitals
- 2
- Verified
- 1
- Price from
- Price on request
Verified surgeons for Ocular Oncology Surgery
1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
Ocular oncology surgery in Turkey: what it is and how it works
Ocular oncology surgery encompasses specialised surgical interventions to diagnose, biopsy, and treat tumours of the eye, eyelids, and orbit. Conditions treated include intraocular malignancies like uveal (choroidal, ciliary body, and iris) melanoma and retinoblastoma, alongside ocular surface tumours and orbital lesions. The primary aim of ocular oncology surgery in Turkey is tumour control to safeguard life, followed by preserving the physical eye and functional vision whenever clinically possible.
Surgical methods depend on tumour type, size, and location. Eye-sparing options include plaque brachytherapy—attaching a small radioactive disc (iodine-125 or ruthenium-106) to the sclera over the tumour base—and local resection (sclerouvectomy) to excise the lesion while sparing healthy ocular tissue. When tumours are too large or vision cannot be saved, enucleation (removal of the eyeball) with a porous orbital implant provides definitive tumour clearance. For broader systemic cancer care, see our guide to oncology treatments in Turkey.
Does ocular oncology surgery actually work and what does evidence show?
Yes. Extensive clinical evidence demonstrates that modern ocular oncology surgery achieves high rates of local tumour control. The landmark Collaborative Ocular Melanoma Study (COMS), a major multicentre randomised trial, showed that eye-preserving plaque brachytherapy provides five-year and ten-year overall survival rates equivalent to enucleation for medium-sized choroidal melanomas, with local tumour control exceeding 90 to 95 percent. These findings established plaque radiotherapy as an international standard for globe preservation.
However, expectations must remain realistic. While surgery or radiation destroys the local tumour, neither alters metastatic risk driven by tumour genetics, such as monosomy 3 or BAP1 mutations. Furthermore, radiation to intraocular structures often causes delayed effects over two to five years, such as radiation retinopathy, macular oedema, or cataracts, which can reduce vision. Reputable ocular oncology teams discuss these visual trade-offs clearly before treatment.
Ocular oncology surgery cost in Turkey compared with the UK, US and Germany
The figures below outline approximate price ranges for ocular oncology surgery. These reflect typical hospital ranges rather than fixed quotes, as pricing varies by tumour complexity, technique, isotope requirements, and hospital stay.
| Country | Approximate cost range |
|---|---|
| Turkey | €4,000 – €12,500 |
| United Kingdom | €9,500 – €24,000 |
| United States | €18,000 – €45,000 |
| Germany | €8,500 – €22,000 |
Several factors affect the total ocular oncology surgery cost. Custom radioactive plaque preparation (using Ruthenium-106 or Iodine-125) involves specialised nuclear medicine and dosimetric planning. For enucleation, pricing depends on the porous orbital implant material and custom prosthetic eye fabrication by an ocularist. The final ocular oncology surgery price in Turkey typically includes pre-operative imaging, surgeon and anaesthetist fees, hospitalisation, medication, and initial follow-up checks.
Surgical approaches: plaque brachytherapy, local resection and enucleation
Surgical selection balances tumour eradication against anatomical and visual preservation. In surgical oncology, organ preservation is a key principle. Just as organ-preserving techniques like lumpectomy in breast cancer prioritise removing tumours while conserving tissue, eye-sparing surgeries aim to control malignancy while safeguarding as much viable ocular structure and sight as possible.
| Surgical technique | Best suited to | Typical limits |
|---|---|---|
| Plaque brachytherapy | Small to medium choroidal melanomas and vascular tumours | Risk of progressive radiation retinopathy; unsuitable for tumours touching the optic nerve |
| Local resection (sclerouvectomy) | Iris and ciliary body tumours where radiation risks heavy collateral damage | Requires advanced microsurgical skill; risks bleeding and retinal detachment |
| Enucleation with orbital implant | Large intraocular tumours, blind painful eyes, or recurrent lesions | Complete loss of the biological eye; requires an artificial ocular prosthesis |
In advanced cases with extensive orbital invasion, extended procedures such as orbital exenteration may be necessary. Multidisciplinary evaluation confirms the safest approach for each patient.
How is ocular oncology surgery performed step by step?
Ocular oncology procedures follow meticulous microsurgical steps under general anaesthesia or deep local nerve blocks. Operations usually last between one and three hours depending on complexity.
The procedure follows four key stages:
- Tumour localisation: The surgeon uses indirect ophthalmoscopy, transillumination, and intraoperative ultrasound to map the tumour margins precisely onto the sclera.
- Surgical exposure: A conjunctival opening is created, and rectus muscles are looped with sutures to gently position the eye without elevating intraocular pressure.
- Plaque fixation or tumour excision: In brachytherapy, the radioactive plaque is sutured over the tumour base. In enucleation, the extraocular muscles are detached and the optic nerve is severed with an adequate margin (typically 8 to 12 mm).
- Implant insertion and closure: Following enucleation, a porous spherical implant is placed in the muscle cone to restore volume, muscles are reattached, and a temporary conformer is placed under the lids. For brachytherapy, conjunctiva is closed over the plaque until scheduled removal.
Who is a suitable candidate for eye tumour surgery?
Good candidates include patients with diagnosed intraocular malignancies, suspicious melanocytic lesions showing documented growth or high-risk features, and symptomatic orbital tumours. Patients should be fit for anaesthesia and committed to regular post-operative ophthalmic and systemic surveillance.
Surgery is tailored or deferred if distant metastases are present at diagnosis, where systemic treatment takes priority unless local surgery is needed to alleviate pain. Much like surgical oncology protocols in visceral disease such as the removal of colon cancer, thorough pre-operative staging—including liver function tests, ultrasound, or MRI—is essential before operating on high-risk ocular tumours. Significant extraocular spread or extensive ring melanomas may also rule out globe-preserving techniques in favour of wider excision.
Ocular oncology surgery recovery and prosthetic rehabilitation
Recovery timelines for ocular oncology surgery recovery depend on whether eye-sparing brachytherapy or enucleation was performed. Plaque brachytherapy patients stay in hospital for three to seven days while the plaque delivers its radiation dose, after which a brief procedure removes the device.
For enucleation patients, recovery proceeds in stages:
- Days 1 to 3: A pressure bandage stays in place to minimise swelling and bruising. Mild discomfort and headache are controlled with oral analgesics.
- Weeks 1 to 4: Swelling subsides, and the plastic conformer maintains socket depth. Desk work and light routine activities can resume after one to two weeks, avoiding heavy lifting.
- Weeks 6 to 8: Once socket tissues have healed, an ocularist fits a custom acrylic prosthetic eye, hand-painted to match the fellow eye's colour, sclera, and blood vessels.
Patients travelling for ocular oncology surgery Turkey packages receive clear aftercare instructions, prescription drops, and flight clearance before departure.
Before and after ocular oncology surgery: appearance, vision and prosthetic fitting
Patients often worry about visual ability and cosmetic appearance after surgery. In globe-preserving surgery, the eye's external appearance remains normal. However, surgery and radiation aim to stop tumour growth rather than restore lost sight. Radiation vasculopathy may gradually decrease vision in the treated eye over subsequent years, which patients should anticipate.
After enucleation, modern rehabilitation delivers natural cosmetic outcomes. Integrated porous implants allow orbital muscles to transfer movement to the prosthetic eye. While an artificial eye provides no sight, a custom-fitted prosthesis matches the companion eye so closely that asymmetry is rarely noticeable in everyday interactions. Patients adjust to monocular vision within several weeks, learning simple visual adaptations for depth perception and peripheral awareness.
Risks and complications of eye cancer surgery
Every surgical procedure entails potential risks. Major clinical societies, including the American Academy of Ophthalmology (AAO) and the Royal College of Ophthalmologists (RCOphth), document several recognized complications:
- Radiation-related effects: Plaque brachytherapy can lead to radiation retinopathy, macular oedema, optic neuropathy, cataracts, and neovascular glaucoma. Regular monitoring allows timely management with laser therapy or anti-VEGF injections.
- Surgical complications: Local resection carries risks of intraocular bleeding, vitreous haemorrhage, retinal detachment, and infection (endophthalmitis).
- Socket complications: Following enucleation, risks include haematoma, implant exposure through the conjunctiva, chronic discharge, or deep upper eyelid sulcus.
- Phantom eye sensations: Some patients experience temporary visual sensations or mild awareness of the removed eye, a harmless phenomenon akin to phantom limb syndrome that resolves over time.
How to choose an ophthalmic oncology centre and red flags
Ocular oncology requires collaboration between ophthalmic surgeons, radiation oncologists, medical physicists, pathologists, and certified ocularists. Ensure your surgeon has accredited fellowship training in ocular oncology. The treating hospital must provide certified dosimetric planning, dedicated ocular ultrasound, and pathology capable of cytogenetic tumour profiling (such as BAP1 and chromosome 3 analysis).
Red flags include clinics promising guaranteed vision preservation, surgeons operating without prior liver and chest staging, or quotes lacking clear breakdowns. You can review how it works to understand how medical travel, diagnostic transfers, and specialist consultations are managed. To submit your ophthalmic reports and imaging for review by an ocular oncology team, request a free quote with a detailed surgical assessment.
Key questions to ask your surgical team include:
- What is my tumour's precise size, classification, and proximity to the optic nerve and fovea?
- Am I a candidate for globe-preserving plaque brachytherapy, or is enucleation safer?
- Which isotope will be used, and what is the expected radiation dose to surrounding healthy tissues?
- What type of orbital implant will be placed, and when will my custom prosthetic eye be made?
- What schedule of systemic surveillance (liver scans and clinical reviews) do you recommend after surgery?
Hospitals with Oncology in Turkey
Frequently asked questions
Ocular oncology surgery encompasses surgical procedures used to diagnose, biopsy, and treat benign and malignant tumours of the eye, eyelid, and orbit. Common procedures include plaque brachytherapy, local tumour resection, enucleation (removal of the eyeball while preserving orbital tissues), and exenteration. The primary goal is eradicating the tumour and preserving life, followed by preserving the eye and useful vision whenever clinically possible.
Yes, surgical intervention and radiation-based ocular oncology techniques achieve high rates of local tumour control. Landmark clinical trials, including the Collaborative Ocular Melanoma Study, show local control exceeding 90 to 95 percent for plaque brachytherapy in eligible choroidal melanomas. For advanced tumours requiring enucleation, complete surgical excision provides definitive local eradication when tumour margins and the optic nerve stump are clear.
Ocular oncology surgery in Turkey typically ranges from €4,000 to €12,500, compared with €9,500 to €24,000 in the UK and higher in the US. The exact fee depends on the surgical method, such as custom radioactive plaque fabrication, microsurgical tumour resection, or enucleation with an integrated porous orbital implant and custom prosthetic eye fabrication.
Results depend on whether eye-sparing surgery or enucleation was performed. In globe-preserving procedures, the eye retains its natural appearance, though vision may gradually change from radiation effects. After enucleation, an orbital implant and expertly matched acrylic ocular prosthesis restore natural symmetry, volume, and coordinated movement with the companion eye, creating a natural aesthetic appearance.
Initial surgical wound healing takes two to four weeks. If temporary plaque brachytherapy is performed, the radioactive plaque remains in place for three to seven days before surgical removal. For enucleation patients, temporary swelling and bruising subside within three to four weeks, and a custom prosthetic eye is fitted once socket tissues have fully healed at six to eight weeks.
The procedure is carried out under general anaesthesia or deep regional nerve blocks, ensuring you feel no pain during surgery. Post-operative discomfort, orbital pressure, or mild headache is common during the first few days, but these symptoms are readily controlled with prescribed analgesics, anti-nausea medications, and protective eye dressings.
When primary intraocular or orbital tumours are successfully excised or sterilised with adequate margins, local surgical control is permanent in the majority of cases. However, because certain ocular malignancies carry lifelong risks of delayed systemic metastasis, patients require ongoing surveillance with periodic hepatic imaging, chest scans, and comprehensive ophthalmic examinations.
When performed by subspecialist ophthalmic oncologists in tertiary hospitals, ocular oncology procedures have established safety profiles. As with all oncological surgery, potential complications exist, including infection, intraocular haemorrhage, radiation retinopathy, or implant exposure. These risks are minimised through precise pre-operative imaging, specialised microsurgical techniques, and dedicated multidisciplinary follow-up care.
Plaque brachytherapy delivers targeted radiation to destroy the intraocular tumour while preserving the physical eyeball and often some degree of functional vision. Enucleation involves complete surgical removal of the eye globe, reserved for large tumours, severe secondary complications, or blind painful eyes. Clinical studies demonstrate equivalent long-term overall survival rates between both modalities for medium-sized choroidal melanomas.
Most international patients stay in Turkey for seven to ten nights. This allows sufficient time for comprehensive pre-operative ophthalmic imaging and systemic staging, the surgical procedure (including plaque placement and removal when brachytherapy is used), post-operative wound inspection, and clearance from your ophthalmic surgeon prior to your flight home.
Patient stories